People living with HIV often require higher doses of other vaccines
A group of B.C. and Ontario researchers are beginning a study on the effectiveness of COVID-19 vaccines on people living with HIV.
The $2.6 million study, funded by the federal government, Canadian Institutes of Health Research and and Stop the Spread Ottawa, will recruit 400 people with HIV from clinics in Vancouver, Montreal, Ottawa and Toronto.
“There have been very limited data from clinical trials for this at-risk community,” said principal investigator Dr. Aslam Anis, national director of the CIHR Canadian HIV Trials Network and director of the University of British Columbia’s School of Population and Public Health.
Click here for the full story on Vernon Morning Star.